Accelerating the Development of Next Generation Bioconjugate Drugs Through an Integrated Platform

• Overviewing the challenges in bioconjugation CMC development for novel NDCs
• Case study examples: Exploring strategies and fit for purpose solutions for complex bioconjugation processes development
• Overviewing AsymChem/AsymBio’s integrated capabilities in NDC CDMO services

Speakers:

Tiejun Li

Vice General Manager

Asymchem Laboratories Inc.